2022 Annual Meeting | C22 - Controversies in Stroke Treatment and Prevention

��ɫ��

2022 Annual Meeting | C22 - Controversies in Stroke Treatment and Prevention

Date Saturday 04/02/22

Time 02:45 PM - 04:45 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Pierre Fayad, MD, FAHA, FAAN

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives Participants should become familiar with areas in stroke treatment and prevention where evidence is lacking or insufficient to formulate clear recommendations, or where new evidence has emerged that challenges the current consensus. This course is devised to address thoroughly a selected group of such controversial areas and provide the attendees with practical approaches to help them sort through such situations.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
02:45 PM - 02:50 PM PDT	Introduction	Program Overview and Speakers Introduction Pierre Fayad, MD, FAHA, FAAN
02:45 PM - 04:45 PM PDT	Speaker	walk in slides Pierre Fayad, MD, FAHA, FAAN
02:50 PM - 03:20 PM PDT	Speaker	Controversies in Acute and Endovascular Management of Stroke Thabele M. Leslie-Mazwi, MD
03:20 PM - 04:00 PM PDT	Speaker	Controversies in Infectious Diseases and Stroke Avindra Nath, MD, MBBS, FAAN
04:00 PM - 04:30 PM PDT	Speaker	Controversies in Stroke Prevention Pierre Fayad, MD, FAHA, FAAN
04:30 PM - 04:45 PM PDT	Q&A	Live Q&A Pierre Fayad, MD, FAHA, FAAN, Avindra Nath, MD, MBBS, FAAN, Thabele M. Leslie-Mazwi, MD

Faculty Disclosures
Avindra Nath, MD, MBBS, FAAN	The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
Pierre Fayad, MD, FAHA, FAAN	Dr. Fayad has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fayad has received personal compensation in the range of $0-$499 for serving as a Member Data Safety & Monitoring Committee with NINDS.
Thabele M. Leslie-Mazwi, MD	Dr. Leslie-Mazwi has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��